MedPath

KERMAN UNIVERSITY OF MEDICAL SCIENCES

🇮🇷Iran
Ownership
-
Established
1978-01-01
Employees
-
Market Cap
-
Website
http://www.kmu.ac.ir/

Clinical Trials

529

Active:0
Completed:208

Trial Phases

6 Phases

Early Phase 1:6
Phase 1:20
Phase 2:82
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (527 trials with phase data)• Click on a phase to view related trials

Not Applicable
291 (55.2%)
Phase 3
121 (23.0%)
Phase 2
82 (15.6%)
Phase 1
20 (3.8%)
Phase 4
7 (1.3%)
Early Phase 1
6 (1.1%)

Identification of Important Symptoms and Diagnostic Hypothyroidism Patients Using Machine Learning Algorithms

Completed
Conditions
Prediction Hypothyroidism Patients Using Machine Learning Algorithms
Identification of Important Symptoms of Hypothyroidism
First Posted Date
2023-11-02
Last Posted Date
2023-11-02
Lead Sponsor
Kerman University of Medical Sciences
Target Recruit Count
1296
Registration Number
NCT06112886
Locations
🇮🇷

Faculty of Health, Kerman University of Medical Sciences, Kerman, Iran, Islamic Republic of

Population Pharmacokinetics of Imatinib in CML Patients in Iran

Terminated
Conditions
Chronic Myelogenous Leukemia
Interventions
First Posted Date
2014-05-26
Last Posted Date
2016-09-07
Lead Sponsor
Kerman University of Medical Sciences
Target Recruit Count
170
Registration Number
NCT02146846
Locations
🇮🇷

Shahid-Bahonar hospital, Kerman, Iran, Islamic Republic of

News

No news found
© Copyright 2025. All Rights Reserved by MedPath